Mr. Pesicka was named President & Chief Executive Officer of Owens & Minor, effective March 7, 2019, and was appointed to the Board of Directors at the same time. Prior to that, Mr. Pesicka served as an independent consultant and advisor in the healthcare, life science and distribution industries since January 2016. From January 2000 through April 2015, he served in various roles of increasing responsibility at Thermo Fisher Scientific, a $17 billion manufacturer and supplier of a range of products to the research, healthcare, industrial and safety markets, including most recently as Chief Commercial Officer & Senior Vice President. Before joining Thermo Fisher Scientific, Mr. Pesicka spent eight years at TRW Inc., in a variety of finance roles and three years with PricewaterhouseCoopers as an auditor.

Perry was appointed Executive Vice President, Chief Executive Officer, Patient Direct effective March 1, 2023.  Prior to that, Perry was Chief Executive Officer of the Company’s Byram Healthcare division, a position he from 2009 to March 1, 2023. Perry joined Byram Healthcare in 2006 as its Chief Operating Officer, having previously served as Chief Operating Officer of Hemophilia Resources of America for five years prior to its sale to Accredo Health. Earlier in his career, Perry also spent 18 years at Caremark/Coram in increasingly responsible positions within Operations, General Management within Coram Resource Network and as SVP Operations.

Alex was appointed Executive Vice President & Chief Financial Officer of Owens & Minor, effective October 12, 2022. Previously, Alex served as the Senior Vice President, Finance – Patient Direct segment from August 2022 to the present. Prior to that, Alex served as Senior Vice President, Finance – Products & Healthcare Services segment from January 2022 to August 2022, and Senior Vice President, Finance - Global FP&A, Medical Distribution, Services, and Outsourced Logistics from April 2020 to January 2022. Prior to joining the Company from 2019 to 2020, Mr. Bruni served as Chief Financial Officer & Chief Operating Officer for Centerline Communications, a services company providing infrastructure solutions to the wireless telecommunications industry. From 2018 to 2019, Alex was Chief Financial Officer and Chief Operating Officer for Torque Therapeutics, an immune-oncology company, where he led finance, manufacturing and corporate operations. Prior to joining Torque Therapeutics, he served from 2012 until 2018 in multiple Vice President positions including Finance, Corporate FP&A, Continuous Improvement and Corporate Development at Patheon, a pharmaceutical company.

Executive Vice President, General Counsel and Corporate Secretary since May 2023. After joining Owens & Minor in 2013 until 2016, Heath served as Assistant General Counsel. He was promoted to Vice President, Associate General Counsel in 2016. Prior to joining the company, Heath was a Partner at the law firm of Williams Mullen, PC.

Tammy was appointed Executive Vice President & Chief Human Resources Officer, effective July 11, 2022. Previously, Tammy served as SVP, Global Human Resources Centers of Excellence & Human Resources Services for Cardinal Health, from 2021 to July 2022. In this role she was responsible for compensation, benefits, talent acquisition, talent management, human resources operations and analytics. Prior to that from 2015 to 2021, Tammy was SVP, HR Business Partner and from 2005 to 2015, Tammy held various vice president human resources business partner roles supporting Cardinal Health’s business and functional leaders. She began her career in finance, working with Prudential and General Motors.

Jon was named Senior Vice President, Corporate Treasurer of Owens & Minor in May 2018. Prior to that, he served as Vice President, Treasurer, after joining Owens & Minor in January of 2017. Before joining Owens & Minor, Jon worked for the Brinks Company for nine years, beginning in 2008, where he served as Treasurer. He has extensive experience in treasury management. Jon earned his degree at the University of Connecticut.

Andy was appointed Executive Vice President, Chief Executive Officer, Products & Healthcare Services, effective October 12, 2022. Prior to that, Andy was Executive Vice President & Chief Financial Officer, since joining the Company in November 2019. Previously, Andy served as the Chief Executive Officer of Insys Therapeutics, Inc. (“Insys”) from April 2019 to November 8, 2019 and as the Chief Financial Officer of Insys from August 2017 until April 2019. Prior to joining Insys, Mr. Long served as senior vice president of Global Finance at Patheon, a pharmaceutical company, from 2015 to 2017. Prior to Patheon, Mr. Long served as Vice President of Finance for multiple divisions at Thermo Fisher Scientific from 2006 until 2015.

Mike was named Chief Accounting Officer in June 2018. Mike, who joined Owens & Minor in 1988, has held a variety of leadership positions on the Finance Team at Owens & Minor. He previously served as Senior Vice President & Controller from 2013 to 2018. Before that, Mike served as Treasurer from 2009 to 2013.

Dan has served as Executive Vice President, Business Excellence since March 2023. Dan joined Owens & Minor as Executive Vice President, President, Patient Direct & CEO, Apria in March 2022 upon Owens & Minor’s acquisition of Apria, Inc..  Prior to that Dan served as the Chief Executive Officer for Apria, a leading provider of home healthcare equipment delivery and in-home clinical services for COPD, sleep apnea, diabetes, wound therapy and more from February 2015 through March 29, 2022. Prior to that from April 2012, Mr. Starck was the Chief Executive Officer of the Apria home respiratory therapy and home medical equipment segment. Prior to Apria, Mr. Starck served as Chief Executive Officer of CorVel Corporation from 2006 to 2012.